Health And Medicine
-
VUSN study seeks to improve lymphedema care
A new Vanderbilt University School of Nursing (VUSN) study may lead to earlier detection and better outcomes for the 20-30 percent of breast cancer patients with lymphedema, the painful and stigmatizing arm swelling that often results from treatment. Read MoreOct 16, 2014
-
Lymphocyte study reveals obesity clues
Vanderbilt University researchers are closer to understanding the link between obesity, chronic inflammation and type 2 diabetes. Read MoreOct 16, 2014
-
Antibiotics, fetal vessel defect linked
Certain antibiotics increase the risk of a congenital heart disorder called patency of the ductus arteriosis. Read MoreOct 15, 2014
-
Neuronal culprit in genetic disease
A particular neuronal cell population is involved in the pathogenesis of a rare neurological disorder, Vanderbilt researchers have discovered. Read MoreOct 14, 2014
-
New faculty: Neal will train next generation of nurse-midwives
Cesarean delivery is the most common major surgery in the United States. Although sometimes necessary for the health of mother or child, Jeremy Neal thinks too many C-sections are done without good rationale, contributing to adverse health outcomes. Read MoreOct 13, 2014
-
Aspirin and allergies
Drugs such as aspirin and indomethacin may increase sensitivity to airborne allergens by suppressing production of the signaling molecule PGI2, which in turn may offer a new treatment for allergies. Read MoreOct 10, 2014
-
Neuert receives New Innovator Award from NIH
Vanderbilt University biophysicist Gregor Neuert, Ph.D., M.Eng., is among 50 recipients of the 2014 National Institutes of Health (NIH) Director’s New Innovator Award. Each award provides up to $1.5 million in direct research support over five years. Read MoreOct 9, 2014
-
Study finds college athletes more likely to harbor MRSA
College athletes who play contact sports are more than twice as likely to carry the deadly superbug methicillin-resistant Staphylocuccus aureus (MRSA) than peers who play non-contact sports, according to a Vanderbilt study released at IDWeek 2014. Read MoreOct 9, 2014
-
Immune cells that guard against ingested pathogens discovered
Vanderbilt investigators have discovered a new type of immune cell residing in the intestinal epithelium that may function as a first line of defense against ingested pathogens. Read MoreOct 9, 2014
-
Long-range signaling to stem cells
The potential for long-range signaling factors – such as those identified in the current study – to regulate stem cell behaviors has implications in tumor progression and metastasis. Read MoreOct 9, 2014
-
New faculty: Jordan studies sleep disorders in children
As one of the few board-certified pediatric sleep specialists in the region, Atia Jordan works with a multidisciplinary team to address sleep concerns in an effort to improve the overall health and well-being of her patients. Read MoreOct 8, 2014
-
New faculty: Maxwell studies trauma recovery in older population
Working in trauma and critical care for most of her career, Cathy Maxwell noticed profound differences among older patients and their responses to injury. Her curiosity led her to become a nurse researcher in this area. Read MoreOct 3, 2014
-
Low-dose aspirin’s protective effect in cancer explained
For years, scientists have known that regular aspirin use may reduce the risk of cancer. Read MoreOct 2, 2014
-
Traditional healers contribute to HIV care delays: study
If you’re a native of rural Mozambique who contracts HIV and becomes symptomatic, before seeking clinical testing and treatment, you’ll likely consult a traditional healer. Read MoreOct 2, 2014
-
Team spots key regulator for cholesterol production
A Vanderbilt University-led research team has discovered a “master regulator” for cholesterol production and transport in the liver — a tiny piece of RNA called microRNA-223. Read MoreOct 2, 2014
-
Regenerative visual neuroscience effort launched
Vanderbilt University has launched a regenerative visual neuroscience initiative to develop new ways of treating — and restoring sight to — people who have been blinded by glaucoma, macular degeneration, diabetic retinopathy and eye injuries. Read MoreOct 2, 2014
-
Optical imaging in drug therapy screens
A non-invasive imaging tool could test potential cancer therapies quickly to personalize therapy for patients. Read MoreOct 1, 2014
-
Seizure mutation impairs receptor
Defects in the production of certain receptors are linked to the pathogenesis of genetic epilepsies and fever-induced seizures. Read MoreSep 30, 2014
-
Biomarker for diabetic eye disease
A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies. Read MoreSep 26, 2014
-
A path to sarcoidosis treatment
Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis. Read MoreSep 25, 2014